Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg
Clinical trial NCT00649051 · COMPLETED
Trial details
- NCT number
- NCT00649051
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2002-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.